8 popular cold drugs at risk of being prohibited after a new FDA decision
An advisory panel for the agency has concluded that a common ingredient is ineffective.
The cold and flu season is preparing to storm the United States. During the fall and winter, many of us expect to wake up with the blocked nose and the rough gorges, but you can have more harm Find medication To relieve your symptoms this year. Indeed common decongestant To be ineffective - and it is in many over -the -counter medications to which you probably turn. Read the rest to discover eight popular cold drugs that could soon be prohibited.
The FDA investigated a common decongestant.
Phenylephrine is a nasal decongestant This is like an ingredient in many common and allergic drugs, according to Medlineplus of the National Library of Medicine in the United States. It was First approved by the FDA for over -the -counter use (OTC) in the 1970s, by NBC News.
But on September 11, the agency's without prescription advisory committee (NDAC) began a two -day advisory meeting to reassess the effectiveness of the medication. As explained in a briefing Published before the meeting, the FDA said that the Advisory Committee would discuss new efficiency data to determine whether oral phenylephrine should be able to keep its classification "generally recognized as safe and efficient" (Gras).
The agency's advisory council now indicates that it does not work at all.
After examining and discussed the available data, the NDAC held a vote Among its members on the effectiveness of phenylephrine on September 12.
The 16 members of the Committee voted unanimously no , determining that the ingredient is ineffective and no better than a placebo, The New York Times reported.
"I think we clearly have better options in the over -the -counter space to help our patients, and studies do not argue that this is an effective" "drug Maria Coyle , president of the NDAC and associate professor of pharmacy at Ohio State University, said in a statement, according to The New York Times .
In relation: It is not only Adderall - these drugs are also faced with shortages now . AE0FCC31AE342FD3A1346EBB1F342FCB
Many popular cold drugs contain phenylephrine.
Phenylephrine is used to relieve nasal discomfort, sine congestion and pressure - both in itself and in combination with other drugs, according to Medlineplus. Sudafed PE is the most recognizable brand for phenylephrine alone, but decongestant is also used in combination with other pain relievers symptoms in many of the most popular cold drugs currently on the market.
The presentation of the FDA panel said that phenylephrine can be found in at least 250 products that generated nearly $ 1.8 billion in sales last year, The New York Times reported. This includes eight cold drugs that you have probably used, by Medlineplus: Advil Congestion Relief; Choid mucicinex mucicinex mucicinex; Allergy and cold of the children of Pediacare; Robitinin Night Time Toux et Cold; Pe Sudafed Cold / Toux; Tylenol Cold Cold Multi-Symptom Nighttime; Vicks Dayquil Cold and flu -likeness; and Vicks Nyquil Sinex Nighttime Sinus Relief.
These drugs may risk being prohibited.
Now that the Advisory Committee has voted that phenylephrine is not effective, the ball is in the court of the FDA. The agency told NDAC that it would take its Advice in consideration , but did not give a chronology for when he would make his final decision, CNN reported.
The FDA is not required to follow the recommendations of its advice panels, but it generally does, according to The New York Times . So, if the FDA decides to agree with the NDAC and to revoke the state of the fat of phenylephrine, the drugs containing this ingredient could be prohibited and drawn from the shelves of the stores.
"We really should not have products on the market that are not effective", member of the NDAC Committee Diane Ginsburg , PHD, from the University of Texas to the Austin College of Pharmacy, said in a statement according to the vote, by CNN.
But the officials did not question the safety of these products.
While we are waiting for the FDA final decision, experts advised consumers not to go ahead and throw all cold medicines in their pharmacy cabinet, according to The New York Times . The agency's advisers said they did not think that these products were dangerous to use, even if they contain ineffective phenylephrine. In addition, other drug ingredients can actually work to alleviate the symptoms of colds.
Instead, officials are simply worried about costs or care delays that consumers can suffer when "taking a medication that has no advantage".
"It is incredible the amount of dollars spent for something that has really no efficiency", William Fig , Pharmd, clinical pharmacologist and investigator at the National Cancer Institute, said in a statement by CNN.
In relation: For more information, register for our daily newsletter .